BASF's Share Price Creeps Toward Its Peak as Price Hikes, Buybacks, and a Slimmed-Down Portfolio Converge
Published on 09/03/2026 at 18:41 | Editorial boerse-global.de
The chemicals giant is closing in on its 52-week high from multiple directions at once. BASF shares traded at €53.59, just 2.7% below the €55.05 peak reached on April 14, with the stock up 21% since the start of the year. The advance reflects a confluence of pricing power, capital discipline, and portfolio reshaping that has investors reassessing the Ludwigshafen-based group.
Pricing Muscle Meets Supply Constraints
August brought a fresh round of price increases across BASF's specialty chemicals portfolio. In Europe, the company raised neopentyl glycol prices by €250 per tonne and 1,6-hexanediol by €300 per tonne, effective immediately or according to existing contract terms. Across the Atlantic, NEOL neopentyl glycol prices in the US and Canada are set to climb by $221 per tonne from September 1.
These moves land in a market environment where competitors are struggling to deliver. The Ifo business climate index for Germany's chemical industry improved markedly in August, and BASF counts among the companies that have recently lifted their annual profit forecasts, helped by price and demand effects stemming from supply disruptions outside Europe. Where rivals fall short, BASF can defend — or expand — its margins.
Yet the company is not immune to logistical headaches of its own. Extremely low Rhine water levels have hampered deliveries of certain products, with reports in mid-August already flagging shipment difficulties. For the Ludwigshafen Verbund site, which depends heavily on water transport, low river levels remain a recurring operational risk during the summer months.
A Steady Stream of Buybacks
The pricing strategy runs parallel to a sustained capital-return program. Late July saw BASF's board approve a new share buyback of up to €1.0 billion, scheduled to run from August 2026 through April 2027. It forms part of the broader €4 billion program announced in September 2024, which extends to the end of 2028.
Execution has been brisk. During the week of August 17–21, the company repurchased 557,966 of its own shares, followed by another 591,251 in the subsequent week. These purchases build on earlier activity: between November 2025 and June 2026, BASF bought back shares worth roughly €1.5 billion. More than 31.6 million shares — equivalent to nearly 3.5% of share capital — are slated for cancellation, permanently reducing the share count and providing a tailwind to earnings per share.
The Coatings Windfall and a Leaner Balance Sheet
The buybacks rest on a foundation that has recently outperformed expectations. Preliminary second-quarter 2026 figures, released in mid-July, showed EBITDA before special items of €2.4 billion, comfortably beating analyst forecasts. Revenue climbed to €17.2 billion, up €2.4 billion year-on-year, driven by an 11.5% price increase and 7.3% volume growth. Management responded by raising full-year guidance to EBITDA before special items of €6.9–7.7 billion.
The balance sheet has also been deliberately streamlined. The sale of the Coatings business to Carlyle, completed just over a month ago, generated a pre-tax cash inflow of roughly €5.8 billion on an enterprise value of €7.7 billion. BASF retains a 40% stake in the successor company, Surventis. The share price has gained 14.8% since that transaction closed. An early repayment of bonds and loans with a nominal volume of €1.6 billion, executed around a month ago, has contributed to a further 6.5% advance.
Speaking of managing operational risks — chemical manufacturers know that documenting workplace hazards is just as critical as managing supply chains. A free Risk Assessment Toolkit with 41 ready-to-use templates and checklists helps you identify and document risks before they become costly incidents. Download the free Risk Assessment Toolkit
Portfolio Moves and the AgChem IPO Track
Beyond coatings, the portfolio overhaul continues on multiple fronts. In May, BASF signed an agreement to sell its silicates business to PQ, with completion expected in the second half of 2026. In the agricultural segment, BASF Agricultural Solutions closed the acquisition of AgBiTech from Paine Schwartz Partners at the end of March, strengthening its biological crop protection offering.
The most closely watched development remains the planned initial public offering of the agricultural division. Board member Livio Tedeschi said in August that the company would focus fully on a potential listing next year, with the groundwork expected to be complete by mid-2027. Frankfurt is the intended venue, and the listing as a Societas Europaea is seen as a milestone in the "Winning Ways" strategy.
Management changes accompanied the strategic shift: Mary Kurian and Livio Tedeschi joined the board on May 1, while Michael Heinz retired. Investors get their next formal update on October 28, when BASF publishes third-quarter results.
A Two-Sided Picture for Investors
The stock's technical position reflects the improving narrative. Trading with a relative strength index of 66.7, the shares sit in a zone of elevated demand without yet being overbought. The distance to the 200-day moving average stands at 10%, underscoring the momentum of recent months.
For shareholders, the equation is straightforward but not without caveats: pricing power and a favorable industry backdrop support earnings prospects, while weather-dependent logistics on the Rhine remain a seasonal risk that could resurface depending on water levels in the weeks ahead. The recent price increases, the steady cadence of buybacks, and the proceeds from divestitures all point in the same direction — but the path to a new high runs through Ludwigshafen's river logistics as much as through its pricing strategy.
